Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis

Cancer Research

Volumn 71, Issue 13, 2011, Pages 4432-4442

  Besmer, Dahlia M ^a   Curry, Jennifer M ^a   Roy, Lopamudra D ^a   Tinder, Teresa L ^a   Sahraei, Mahnaz ^a   Schettini, Jorge ^a   Hwang, Sun Il ^b   Lee, Yong Y ^b   Gendler, Sandra J ^c   Mukherjee, Pinku ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b Carolinas Health Care Center   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALPHA TUBULIN; EPIDERMAL GROWTH FACTOR; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN 1; NESTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN CDC 25C; PROTEIN TUBULIN ALPHA2; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CARCINOGENICITY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; NULL CELL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; TUMOR CELL LINE; TUMOR GROWTH; TUMOR MODEL; WESTERN BLOTTING;

ANIMALS; BUTADIENES; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE; CELL GROWTH PROCESSES; EPIDERMAL GROWTH FACTOR; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MUCIN-1; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; NITRILES; PANCREATIC NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE INHIBITORS; TUBULIN;

EID: 79959891751     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-4439     Document Type: Article

References (24)

1. Saif MW. Pancreatic cancer: highlights fromthe 42nd annualmeeting of the American Society of Clinical Oncology 2006. JOP 2006;7:337-48.
2. Acres B, Limacher JM. MUC1 as a target antigen for cancer immunotherapy. Expert Rev Vaccines 2005. 4:493-502. (Pubitemid 41297296)
3. Tinder TL, Subramani DB, Basu GD, Bradley JM, Schettini J, Million A, et al. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. J Immunol 2008;181:3116-25.
4. Levi E, Klimstra DS, Andea A, Basturk O, Adsay NV. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol 2004;57:456-62. (Pubitemid 38621788)
5. Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 2003;99:365-71. (Pubitemid 38017536)
6. Adsay NV, Basturk O, Cheng JD, Andea AA. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Semin Radiat Oncol 2005;15:254-64. (Pubitemid 41377141)
7. Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002;15:1087-95.
8. Moniaux N, Andrianifahanana M, Brand RE, Batra SK. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer 2004;91:1633-8. (Pubitemid 39546133)
9. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4: 437-50. (Pubitemid 38050041)
10. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437-450. (Pubitemid 38050041)
11. Adhikary R, Mukherjee P, Krishnamoorthy G, Kunkle RA, Casey TA, Rasmussen MA, et al. Fluorescence spectroscopy of the retina for diagnosis of transmissible spongiform encephalopathies. Anal Chem 2010;82:4097-101.
12. Mukherjee P, Basu GD, Tinder TL, Subramani DB, Bradley JM, Arefayene M, et al. Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. J Immunol 2009;182:216-24.
13. Spicer AP, Rowse GJ, Lidner TK, Gendler SJ. Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem 1995;270:30093-101. (Pubitemid 26001684)
14. Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, et al. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene 2011;30:1449-59.
15. Hoang MV, Nagy JA, Senger DR. Cdc42-mediated inhibition of GSK-3beta improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis. Microvasc Res 2011;81:34-43.
16. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-6.
17. Sheng H, Shao J, Washington MK, DuBois RN. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001;276:18075-81.
18. Wang R, He G, Nelman-Gonzalez M, Ashorn CL, Gallick GE, Stukenberg PT, et al. Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell 2007;128:1119-32. (Pubitemid 46437261)
19. Kalluri HS, Vemuganti R, Dempsey RJ. Mechanism of insulin-like growth factor I-mediated proliferation of adult neural progenitor cells: role of Akt. Eur J Neurosci 2007;25:1041-8.
20. Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y, et al. Nestin expression-a property of multi-lineage progenitor cells?Cell Mol Life Sci 2004;61:2510-22.
21. Beckers T, Reissmann T, Schmidt M, Burger AM, Fiebig HH, Vanhoefer U, et al. 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. Cancer Res 2002;62:3113-9. (Pubitemid 34602403)
22. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009;9:874-85.
23. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001;6:339-53.
24. Schroeder JA, Masri AA, Adriance MC, Tessier JC, Kotlarczyk KL, Thompson MC, et al. MUC1 overexpression results inmammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene 2004;23:5739-47. (Pubitemid 39093019)